O'Shaughnessy Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
6,436
+2,633
| +69% | +$859K | 0.01% | 752 |
|
|
2025
Q1 | $1.03M | Buy |
3,803
+360
| +10% | +$97.2K | 0.01% | 973 |
|
|
2024
Q4 | $810K | Sell |
3,443
-286
| -8% | -$67.3K | 0.01% | 1055 |
|
|
2024
Q3 | $1.06M | Buy |
3,729
+2,736
| +276% | +$775K | 0.01% | 883 |
|
|
2024
Q2 | $241K | Sell |
993
-1,188
| -54% | -$289K | ﹤0.01% | 1466 |
|
|
2024
Q1 | $326K | Buy |
2,181
+191
| +10% | +$28.5K | ﹤0.01% | 1276 |
|
|
2023
Q4 | $381K | Buy |
1,990
+396
| +25% | +$75.8K | 0.01% | 1119 |
|
|
2023
Q3 | $282K | Buy |
1,594
+258
| +19% | +$45.7K | ﹤0.01% | 1146 |
|
|
2023
Q2 | $254K | Buy |
+1,336
| New | +$254K | ﹤0.01% | 1115 |
|
|
2023
Q1 | – | Sell |
-1,008
| Closed | -$240K | – | 1479 |
|
|
2022
Q4 | $240K | Buy |
+1,008
| New | +$240K | ﹤0.01% | 1051 |
|
|
2021
Q4 | – | Sell |
-220
| Closed | -$42K | – | 1297 |
|
|
2021
Q3 | $42K | Buy |
220
+92
| +72% | +$17.6K | ﹤0.01% | 1709 |
|
|
2021
Q2 | $22K | Hold |
128
| – | – | ﹤0.01% | 1805 |
|
|
2021
Q1 | $18K | Hold |
128
| – | – | ﹤0.01% | 1653 |
|
|
2020
Q4 | $17K | Sell |
128
-2
| -2% | -$266 | ﹤0.01% | 1442 |
|
|
2020
Q3 | $19K | Sell |
130
-8
| -6% | -$1.17K | ﹤0.01% | 1256 |
|
|
2020
Q2 | $20K | Buy |
138
+117
| +557% | +$17K | ﹤0.01% | 1145 |
|
|
2020
Q1 | $2K | Buy |
21
+11
| +110% | +$1.05K | ﹤0.01% | 1143 |
|
|
2019
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1712 |
|